publication date: Aug. 2, 2019

In Brief

AACR announces new journal, Blood Cancer Discovery

The American Association for Cancer Research has announced a new journal, Blood Cancer Discovery. The journal will be the ninth in the AACR’s portfolio of scientific publications, including Cancer Discovery.

The first print issue of Blood Cancer Discovery will be published early next year, and papers accepted for publication this year will be published online, according to AACR.

Blood Cancer Discovery will feature high-impact, peer-reviewed articles describing major advances in basic, translational, and clinical research on all subtypes of leukemia, lymphoma, myeloma, and associated diseases.

The founding editors-in-chief will be Riccardo Dalla-Favera and Kenneth C. Anderson. They will work with an editorial board comprised of experts to curate leading blood cancer research studies for inclusion in the monthly journal.

Dalla-Favera is director of the Institute for Cancer Genetics at Columbia University and serves as professor of pathology and cell biology, microbiology and immunology, and genetics and development. His work focuses on the pathogenesis of cancers derived from B lymphocytes, including the testing of novel therapeutic approaches for their ability to target newly discovered genetic lesions and cellular pathways altered in tumors.

Anderson is program director at the Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics at Dana-Farber Cancer Institute and Kraft Family Professor of Medicine at Harvard Medical School. Over the last three decades, Anderson has focused his laboratory and clinical research studies on multiple myeloma, developing laboratory and animal models to better understand the biological mechanisms of the disease.

For more information or to submit a manuscript, visit www.AACRjournals.org/bcd. To learn about the AACR’s publication program, visit Continue reading AACR announces new journal, Blood Cancer Discovery

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2019 The Cancer Letter Inc.